Sublingual semaglutide

Indicaton

obesity and diabetes

Therapeutic indications

Metabolic disorder

Type of product

Peptide

Table

Phase

Discovery
Partnering status

Not partnered

You may also be interested in

OligoPhore / SemaPhore Peptide-Based RNA Delivery Platforms

Delivers siRNA, antisense oligonucleotides, mRNA and other mRNA modalities to extrahepatic tissues - demonstrated across various indications in oncology (e.g. PDAC, breast cancer, ovarian cancer, lung cancer, melanoma, ATLL, TME), and inflammatory / autoimmune diseases (e.g. OA, RA, enterocolitis), CV (e.g. atherosclerosis, aortic aneurysm)

Discovery

A2AR positive allosteric modulator

Multiple, see therapeutic areas. GI indications also relevant.

Discovery

DO-10

GM1-gangliosidosis and mucopolysaccharidosis IVB, 2 rare diseases caused by beta-galactosidase deficiency.